Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib in Advanced Bone and Soft Tissue Sarcoma with CDK Pathway Alteration
NCT04040205Phase 2Recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Oct 2019
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in chondrosarcoma, osteosarcoma (OS), soft tissue sarcoma (STS), chordoma, sponsored by Medical College of Wisconsin. Started Oct 2019; status: recruiting.
02
Drugs
abemaciclib
03
Conditions
chondrosarcomaosteosarcoma (OS)soft tissue sarcoma (STS)chordoma
Beyond the preview
Go deeper on NCT04040205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04040205.